Expert Q&A: Why Personalized Medicine Is Transforming Oncology – and What It Means for the Market
Personalized medicine is reshaping cancer treatment, offering new ways to target the disease based on each patient’s unique genetic profile. Unlike traditional chemotherapy - which broadly targets cancer cells but often harms healthy tissue - personalized treatments hone in on the specific pathways driving an individual’s cancer. Dr. Tong Dai, a board-certified oncologist with over a decade of experience, has dedicated his career to advancing these targeted therapies. His work spans leading-edge research and hands-on patient care, including pivotal clinical trials that helped bring breakthrough immunotherapies like Keytruda to patients with difficult-to-treat cancers.
